Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

M2 antagonists reported by Yamanouchi

July 5, 1996

Kyowa Hakko's OXT displays cardiotonic and insulin release-promoting effects

July 5, 1996

NEP inhibitors claimed by Santen

July 5, 1996

AHP describes tricyclic benzazepine vasopressin antagonists

July 5, 1996

Warner-Lambert reports nonpeptide ET antagonists

July 5, 1996

Uriach research into PAF antagonists continues

July 5, 1996

Cephalon reveals multicatalytic protease inhibitors

July 5, 1996

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data
BioWorld
Impressive results of a potential second-line combination treatment for multiple myeloma from the Majestec-3 trial of teclistamab plus daratumumab raised eyebrows...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...